Maximizing the value of genomic knowledge for biological research
Ilya Kupershmidt, VP of product management, NextBio
Mr. Kupershmidt has had extensive experience in the design, implementation, and integration of bioinformatics solutions
for organizations involved in basic research, clinical and drug discovery efforts. An especially relevant area of
Mr. Kupershmidt's expertise derives from his years at Silicon Genetics. There he helped develop and market software
widely used for data mining and management of information from high-throughput genomic and proteomic platforms. Mr.
Kupershmidt joined Silicon Genetics at the company's inception, and has since worked with hundreds of academic
institutions and commercial enterprises on the design, customization, and deployment of systems for global analysis
and management of high-throughput biological information. In his role as Director of Professional Services, he worked
closely with such institutions as Novartis, AstraZeneca, Pfizer, Merck, Bayer, Stanford, Harvard, MIT and others, on
implementing effective bioinformatics solutions. Previously, Mr. Kupershmidt carried out research at Geof Rosenfeld's
lab at UCSD Howard Hughes Medical Institute. There he studied transcriptional mechanisms of gene expression
regulation during pituitary development. Mr. Kupershmidt is currently a Ph.D. candidate at the Royal
Institute of Stockholm (KTH), Stockholm, Sweden.
